Fusion Peptides CPU1 and CPU2 Inhibit Matrix Metalloproteinases and Protect Mice from Endotoxin Shock Within a Strict Time Window

[1]  P. E. Van den Steen,et al.  Inhibition of Neutrophil Collagenase/MMP-8 and Gelatinase B/MMP-9 and Protection against Endotoxin Shock , 2014, Journal of immunology research.

[2]  Ming Yan,et al.  Chemically synthesized matrix metalloproteinase and angiogenesis-inhibiting peptides as anticancer agents. , 2014, Anti-cancer agents in medicinal chemistry.

[3]  G. Opdenakker,et al.  Zymography methods for visualizing hydrolytic enzymes , 2013, Nature Methods.

[4]  P. E. Van den Steen,et al.  Targeting matrix metalloproteinases in acute inflammatory shock syndromes. , 2012, Combinatorial chemistry & high throughput screening.

[5]  D. Remick,et al.  The pathogenesis of sepsis. , 2011, Annual review of pathology.

[6]  A. Krüger,et al.  Avoiding spam in the proteolytic internet: future strategies for anti-metastatic MMP inhibition. , 2010, Biochimica et biophysica acta.

[7]  S. Mobashery,et al.  Effect of synthetic matrix metalloproteinase inhibitors on lipopolysaccharide-induced blood–brain barrier opening in rodents: Differences in response based on strains and solvents , 2007, Brain Research.

[8]  P. E. Van den Steen,et al.  Inhibition of lethal endotoxin shock with an L-pyridylalanine containing metalloproteinase inhibitor selected by high-throughput screening of a new peptide library. , 2006, Combinatorial chemistry & high throughput screening.

[9]  Mahesh Uttamchandani,et al.  Microarray: a versatile platform for high-throughput functional proteomics. , 2006, Combinatorial chemistry & high throughput screening.

[10]  P. E. Van den Steen,et al.  Targeting neutrophil collagenase/matrix metalloproteinase-8 and gelatinase B/matrix metalloproteinase-9 with a peptidomimetic inhibitor protects against endotoxin shock. , 2005, Biochemical pharmacology.

[11]  P. E. Van den Steen,et al.  Simulation of evolution-selected propeptide by high-throughput selection of a peptidomimetic inhibitor on a capillary DNA sequencer platform. , 2005, Analytical chemistry.

[12]  K. Alitalo,et al.  An Endostatin-derived Peptide Interacts with Integrins and Regulates Actin Cytoskeleton and Migration of Endothelial Cells* , 2004, Journal of Biological Chemistry.

[13]  P. E. Van den Steen,et al.  Inhibitors of gelatinase B/matrix metalloproteinase-9 activity comparison of a peptidomimetic and polyhistidine with single-chain derivatives of a neutralizing monoclonal antibody. , 2004, Biochemical pharmacology.

[14]  G. Opdenakker,et al.  Functional roles and therapeutic targeting of gelatinase B and chemokines in multiple sclerosis , 2003, The Lancet Neurology.

[15]  P. Ward,et al.  Regulation by C5a of neutrophil activation during sepsis. , 2003, Immunity.

[16]  G. Rosenberg,et al.  Closure of the Blood-Brain Barrier by Matrix Metalloproteinase Inhibition Reduces rtPA-Mediated Mortality in Cerebral Ischemia With Delayed Reperfusion , 2003, Stroke.

[17]  G. Opdenakker,et al.  Analysis of Gelatinases in Complex Biological Fluids and Tissue Extracts , 2002, Laboratory Investigation.

[18]  Carlos López-Otín,et al.  Strategies for MMP inhibition in cancer: innovations for the post-trial era , 2002, Nature Reviews Cancer.

[19]  G. Opdenakker,et al.  Gelatinase B deficiency protects against endotoxin shock , 2002, European journal of immunology.

[20]  L. Golub,et al.  Inhibition of matrix metalloproteinase-mediated periodontal bone loss in rats: a comparison of 6 chemically modified tetracyclines. , 2002, Journal of periodontology.

[21]  B. Beutler.  Toll-like receptors: how they work and what they do , 2002, Current opinion in hematology.

[22]  Z. Werb,et al.  How matrix metalloproteinases regulate cell behavior. , 2001, Annual review of cell and developmental biology.

[23]  S. Akira,et al.  Cutting edge: Toll-like receptor 4 (TLR4)-deficient mice are hyporesponsive to lipopolysaccharide: evidence for TLR4 as the Lps gene product. , 1999, Journal of immunology.

[24]  C. Liang,et al.  Human neutrophils secrete gelatinase B in vitro and in vivo in response to endotoxin and proinflammatory mediators. , 1999, American journal of respiratory cell and molecular biology.

[25]  L. Moldawer,et al.  A MATRIX METALLOPROTEINASE INHIBITOR PREVENTS PROCESSING OF TUMOR NECROSIS FACTOR α (TNFα) AND ABROGATES ENDOTOXIN‐INDUCED LETHALITY , 1997 .

[26]  G. Opdenakker,et al.  Induction of gelatinase B and MCP-2 in baboons during sublethal and lethal bacteraemia. , 1997, Cytokine.

[27]  G. Opdenakker,et al.  Production and characterization of recombinant active mouse gelatinase B from eukaryotic cells and in vivo effects after intravenous administration. , 1997, European journal of biochemistry.

[28]  L. Moldawer,et al.  A matrix metalloproteinase inhibitor prevents processing of tumor necrosis factor alpha (TNF alpha) and abrogates endotoxin-induced lethality. , 1997, Shock.

[29]  E. Roets,et al.  The gelatinase inhibitory activity of tetracyclines and chemically modified tetracycline analogues as measured by a novel microtiter assay for inhibitors. , 1996, Biochemical pharmacology.

[30]  L. Shapira,et al.  Protection against endotoxic shock and lipopolysaccharide-induced local inflammation by tetracycline: correlation with inhibition of cytokine secretion , 1996, Infection and immunity.

[31]  G. Opdenakker,et al.  Monoclonal antibodies specific for natural human neutrophil gelatinase B used for affinity purification, quantitation by two-site ELISA and inhibition of enzymatic activity. , 1995, European journal of biochemistry.

[32]  B. Ryffel,et al.  Interferon gamma receptor deficient mice are resistant to endotoxic shock , 1994, The Journal of experimental medicine.

[33]  R. Zinkernagel,et al.  Mice lacking the tumour necrosis factor receptor 1 are resistant to IMF-mediated toxicity but highly susceptible to infection by Listeria monocytogenes , 1993, Nature.

[34]  J. Parrillo.  Pathogenetic mechanisms of septic shock. , 1993, The New England journal of medicine.

[35]  T. Mak,et al.  Mice deficient for the 55 kd tumor necrosis factor receptor are resistant to endotoxic shock, yet succumb to L. monocytogenes infection , 1993, Cell.

[36]  G Murphy,et al.  A novel coumarin‐labelled peptide for sensitive continuous assays of the matrix metalloproteinases , 1992, FEBS letters.

[37]  G. Opdenakker,et al.  Purification and identification of 91-kDa neutrophil gelatinase. Release by the activating peptide interleukin-8. , 1991, European journal of biochemistry.

[38]  H. Birkedal‐Hansen,et al.  The cysteine switch: a principle of regulation of metalloproteinase activity with potential applicability to the entire matrix metalloproteinase gene family. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[39]  S. Weiss.  Tissue destruction by neutrophils. , 1989, The New England journal of medicine.

[40]  A. Granelli‐Piperno,et al.  A study of proteases and protease-inhibitor complexes in biological fluids , 1978, The Journal of experimental medicine.